InsiderClue
← All stocks

NOVAVAX INC

NVAX Net selling
CIK 0001000694 #2303 in the set updated 18 Sep 2026
Bought (120 mo)
$1.47M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$166.65M
$0.00 on a plan · $145.77M straight out of an exercise
Sold at will
$20.89M
146 of 800 sales
Net
−$165.19M
−$19.42M against sales at will

By person

23 insiders · 848 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Erck Stanley C
President and CEO
$319.65K (3)
$47.96M (85) scheduled
−$47.64M
36,492
0.0221%
$291.94K
—
Glenn Gregory M
President, R&D
$135.19K (13)
$42.44M (348) scheduled
−$42.30M
18,339
0.0111%
$146.71K
—
Herrmann John A III
EVP, Chief Legal Officer
$5.56K (1)
$28.20M (164) scheduled
−$28.19M
16,617
0.0101%
$132.94K
—
Trizzino John
President and COO
$185.62K (3)
$26.34M (170) scheduled
−$26.15M
68,061
0.0413%
$544.49K
—
EVANS GARY C
Director
—
$6.85M (4) scheduled
−$6.85M
27,549
0.0167%
$220.39K
+11.4%
MOTT DAVID M
Director
—
$6.31M (5)
−$6.31M
79,770
0.0484%
$638.16K
+22.8%
YOUNG JAMES F
Director
$73.25K (1)
$5.60M (16) scheduled
−$5.53M
53,260
0.0323%
$426.08K
−80.7%
MCMANUS MICHAEL A JR
Director
$76.09K (3)
$2.07M (4) scheduled
−$1.99M
10,101
0.0061%
$80.81K
—
Dubovsky Filip
President, R&D
—
$858.80K (3) scheduled
−$858.80K
66,613
0.0404%
$532.90K
−5.6%
DOUGLAS RICHARD
Director
$357.79K (2)
—
+$357.79K
73,220
0.0444%
$585.76K
—
BOUDREAUX GAIL
Director
$144.85K (1)
—
+$144.85K
200,000
0.1213%
$1.60M
+100.0%
King Rachel K.
Director
$143.31K (4)
$37.44K (1)
+$105.88K
45,170
0.0274%
$361.36K
—
PHILLIPS BARCLAY A
SVP, Chief Financial Officer
$24.61K (3)
—
+$24.61K
38,669
0.0234%
$309.35K
+287.5%
Jacobs John C
President and CEO
—
—
—
225,680
0.1368%
$1.81M
—
O'Hara Elaine
EVP, Chief Strategy Officer
—
—
—
134,642
0.0816%
$1.08M
—
Kelly James Patrick
EVP, CFO and Treasurer
—
—
—
130,599
0.0792%
$1.04M
+5,143%
Casey Mark J
EVP, Chief Legal Officer
—
—
—
90,067
0.0546%
$720.54K
—
Alton Gregg H
Director
—
—
—
47,685
0.0289%
$381.48K
—
Rodgers Richard J
Director
—
—
—
47,370
0.0287%
$378.96K
—
MCGLYNN MARGARET G
Director
—
—
—
44,468
0.0270%
$355.74K
—
Draghia-Akli Ruxandra
EVP, Research & Development
—
—
—
23,563
0.0143%
$188.50K
—
Newton Charles W.
Director
—
—
—
9,520
0.0058%
$76.16K
—
Shiver John W.
Director
—
—
—
7,947
0.0048%
$63.58K
—

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
YOUNG JAMES F
31 Dec 2024
Director
Sell
5,400
$8.00
$43.20K
YOUNG JAMES F
24 Dec 2024
Director
Sell
4,600
$8.48
$39.01K
King Rachel K.
13 Dec 2024
Director
Sell
4,150
$9.02
$37.44K
YOUNG JAMES F
21 Jun 2024
Director
Sell
7,500
$14.09
$105.68K
YOUNG JAMES F
18 Jun 2024
Director
Sell
1,107
$14.28
$15.81K
YOUNG JAMES F
18 Jun 2024
Director
Sell
6,393
$13.62
$87.07K
YOUNG JAMES F
31 Mar 2022
Director
Sell
300
$75.10
$22.53K
YOUNG JAMES F
31 Mar 2022
Director
Sell
3,255
$74.25
$241.68K
YOUNG JAMES F
31 Mar 2022
Director
Sell
8,945
$73.29
$655.55K
Glenn Gregory M
29 Oct 2021
President, R&D
Sell
26
$152.16
$3.96K
Glenn Gregory M
29 Oct 2021
President, R&D
Sell
16
$149.64
$2.39K
Glenn Gregory M
29 Oct 2021
President, R&D
Sell
353
$148.99
$52.59K
Glenn Gregory M
29 Oct 2021
President, R&D
Sell
138
$148.08
$20.44K
Glenn Gregory M
29 Oct 2021
President, R&D
Sell
108
$146.51
$15.82K
Glenn Gregory M
29 Oct 2021
President, R&D
Sell
39
$145.41
$5.67K
Glenn Gregory M
30 Sep 2021
President, R&D
Sell
16
$211.39
$3.38K
Glenn Gregory M
30 Sep 2021
President, R&D
Sell
40
$210.16
$8.41K
Showing 250 of 848 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 361
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 654
Sales at will 146
Transactions with no price 0
Shares from compensation/vesting 3,640,326
Sales filed before the plan box existed 140
History held since 21 Sep 2016